{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:40:08Z","timestamp":1737348008307,"version":"3.33.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clnesp.2024.06.038","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T16:37:30Z","timestamp":1719419850000},"page":"189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Letter to the editor: Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study"],"prefix":"10.1016","volume":"63","author":[{"given":"Yong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clnesp.2024.06.038_bib1","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.clnu.2024.04.013","article-title":"Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: a multicenter study","volume":"43","author":"Wang","year":"2024","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2024.06.038_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/nutrit\/nuab015","article-title":"The complexities of approaching nutrition in inflammatory bowel disease: current recommendations and future directions","volume":"80","author":"Russell","year":"2022","journal-title":"Nutr Rev"},{"issue":"8","key":"10.1016\/j.clnesp.2024.06.038_bib3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s00595-015-1257-5","article-title":"Influence of nutritional status on the therapeutic effect of infliximab in patients with Crohn's disease","volume":"46","author":"Sumi","year":"2016","journal-title":"Surg Today"},{"issue":"2","key":"10.1016\/j.clnesp.2024.06.038_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.gastro.2015.04.016","article-title":"Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis","volume":"149","author":"Brandse","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2024.06.038_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","volume":"71\u201372","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724001840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T03:43:10Z","timestamp":1737344590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724001840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":5,"alternative-id":["S2405457724001840"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.06.038","relation":{},"ISSN":["2405-4577"],"issn-type":[{"type":"print","value":"2405-4577"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter to the editor: Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}